Severe RSV Infection Occurring at the End of Nirsevimab’s Protection Window: A Case Report
We present the case of a five-month-old late preterm infant who developed severe bronchiolitis caused by respiratory syncytial virus, requiring hospitalisation and high-flow nasal cannula support. This occurred 142 days after the infant received a single dose of nirsevimab as part of the regional im...
Saved in:
| Main Authors: | Sebastiano Mazza, Benedetta Ciccone, Anna Maddalena D’Apolito, Caterina Petruccelli, Dalila Tedeschi, Francesca Ippedico, Marianna Lauriola, Stefano Aniello Ferrante, Claudia Baiardi, Anna Calò, Francesca Fortunato, Angelo Campanozzi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Pediatrics |
| Online Access: | http://dx.doi.org/10.1155/crpe/3334926 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Administration of Nirsevimab for RSV Prophylaxis in Infants: A Comprehensive Review
by: Pan-Pan Wu, et al.
Published: (2025-04-01) -
[Complementary Strategy of RSVpreF Vaccination/Nirsevimab versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]
by: Giorgio Lorenzo Colombo, et al.
Published: (2025-07-01) -
Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain
by: Jaime Jesús Pérez Martín, et al.
Published: (2024-12-01) -
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel
by: Bosco Paes, et al.
Published: (2024-12-01) -
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysisResearch in context
by: Daira Trusinska, et al.
Published: (2025-06-01)